1. Harker LA. Cholesteatoma an evidence study. In Cholesteatoma First International Conference, McCabe BF, Sade J, and Abramson M, (eds). Aesculapius Publ: Birmingham, 1997; 308–9.
2. Sculerati N, Bluestone CD. Pathogenesis of cholesteatoma. Otolar- yngol Clin North Am 1989;22:859–68.
3. Yamamoto-fukuda T, Takahashi H, Terakado M, Hishikawa Y, Koji T. Expression of keratinocyte growth factor and its receptor in noncholesteatomatous and cholesteatomatous chronic otitis media. Otol Neurotol 2010;31:745–51.
4. Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngo- scope 2015;125:234–40.
5. Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell 2016;166:21–45.
6. Campbell K. Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis. Curr Opin Cell Biol 2018; 55:30–5.
7. Taneyhill LA. To adhere or not to adhere: the role of Cadherins in neural crest development. Cell Adh Migr 2008;2:223–30.
8. Lv J, Sun B, Mai Z, Jiang M, Du J. CLDN-1 promoted the epithelial to migration and mesenchymal transition (EMT) in human bronchial epithelial cells via Notch pathway. Mol Cell Biochem 2017;432:91–8.
9. Lin X, Shang X, Manorek G, Howell SB. Regulation of the epithelial-mesenchymal transition by Claudin-3 and Claudin-4. PLoS One 2013;8:e67496.
10. Fischer KR, Durrans A, Lee S, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 2015;527:472–6.
11. Zheng X, Carstens JL, Kim J, et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 2015;527:525–30.
12. Puram SV, Parikh AS, Tirosh I. Single cell RNA-seq highlights a role for a partial EMT in head and neck cancer. Mol Cell Oncol 2018;5:e1448244.
13. Koster MI, Dai D, Marinari B, et al. p63 induces key target genes required for epidermal morphogenesis. Proc Natl Acad Sci U S A 2007;104:3255–60.
14. Laurikkala J, Mikkola ML, James M, Tummers M, Mills AA, Thesleff I. p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation. Development 2006;133:1553–63.
15. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714–8.
16. Senoo M, Pinto F, Crum CP, McKeon F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007;129:523–36.
17. Yamamoto-Fukuda T, Akiyama N, Takahashi M, Kojima H. Ker- atinocyte growth factor (KGF) modulates epidermal progenitor cell kinetics through activation of p63 in middle ear cholesteatoma. J Assoc Res Otolaryngol 2018;19:223–41.
18. Ferone G, Mollo MR, Thomason HA, et al. p63 control of desmo- some gene expression and adhesion is compromised in AEC syndrome. Hum Mol Genet 2013;22:531–43.
19. Kratzer I, Vasiljevic A, Rey C, et al. Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier. Histochem Cell Biol 2012;138:861–79.
20. Hamonic G, Pasternak JA, Forsberg NM, Ka¨ser T, Wilson HL. Expression of pattern recognition receptors in porcine uterine epithelial cells in vivo and in culture. Vet Immunol Immunopathol 2018;202:1–10.
21. Wo¨genstein KL, Szabo S, Lunova M, et al. Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules. PLoS One 2014;9: e108323.
22. Ehara H, Koji T, Deguchi T, et al. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybrid- ization and immunohistochemistry. Prostate 1995;27:304–13.
23. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial mesenchy- mal transitions in development and disease. Cell 2009;139:871–90.
24. Blanco MJ, Barrallo-Gimeno A, Acloque H, et al. Snail1a and Snail1b cooperate in the anterior migration of the axial mesendoderm in the zebrafish embryo. Development 2007; 134: 4073–81.
25. Arnoux V, Nassour M, L’Helgoualc’h A, Hipskind RA, Savagner P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell 2008;19:4738–49.
26. Grande MT, Sa´nchez-Laorden B, Lo´pez-Blau C, et al. Snail1- induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med 2015;21:989–97.
27. Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor Budding: The Name is EMT. Partial EMT. J Clin Med 2016;5:. E51.
28. Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composi- tion. Science 2013;339:580–4.
29. Kaufhold S, Bonavida B. Central role of Snail1 in the regulation of EMT and resistance in cancer: A target for therapeutic intervention. J Exp Clin Cancer Res 2014;33:62.
30. Belgiovine C, Chiesa G, Chiodi I, et al. Snail levels control the migration mechanism of mesenchymal tumor cells. Oncol Lett 2016;12:767–71.
31. McGill TJ, Merchant S, Healy GB, Friedman EM. Congenital cholesteatoma of the middle ear in children: A clinical and histo- pathological report. Laryngoscope 1991;101 (6 pt 1):606–13.
32. Kojima H, Tanaka Y, Shiwa M, Sakurai Y, Moriyama H. Congeni- tal cholesteatoma clinical features and surgical results. Am J Otolaryngol 2006;27:299–305.
33. Zhang X, Liu G, Kang Y, Dong Z, Qian Q, Ma X. N-cadherin expression is associated with acquisition of EMT phenotype and with enhancedinvasion in erlotinib-resistant lung cancer cell lines. PLoS One 2013;8:e57692.
34. Koizumi H, Suzuki H, Ohbuchi T, Kitamura T, Hashida K, Naka- mura M. Increased permeability of the epithelium of middle ear cholesteatoma. Clin Otolaryngol 2015;40:106–14.
35. Liebner S, Fischmann A, Rascher G, et al. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 2000;100:323–31.
36. Tsukita S, Furuse M. Occludin and claudins in tight-junction strands: Leading or supporting players? Trends Cell Biol 1999;9:268–73.
37. Lopardo T, Lo Iacono N, Marinari B, et al. Claudin-1 is a p63 target gene with a crucial role in epithelial development. PLoS One 2008;3:e2715.
38. Honda H, Pazin MJ, Ji H, Wernyj RP, Morin PJ. Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem 2006;281:21433–44.
39. Kakuki T, Kurose M, Takano K, et al. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cellcarcinoma. Oncotarget 2016;7:33887–900.
40. Kaneko Y, Kohno T, Kakuki T, et al. The role of transcriptional factor p63 in regulation of epithelial barrier and ciliogenesis of human nasal epithelial cells. Sci Rep 2017;7:10935.